European Patent Office (EPO) grants EU Patent No. EP3583125 B1 covering the Company’s Fully Human Albumin Binding (FHAB®) domain fusion ...
Sonnet BioTherapeutics (SONN) announced that the European Patent Office, EPO, has granted Patent No. EP3583125 B1, entitled “Albumin Binding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback